Accelerating access for greater equity
26 May, 14:00-16:00
Unitaid’s flagship event, this high-level dialogue will focus on our collective efforts to enable access to the most promising advances in global health. Speakers will include ministers of health from Kenya, Spain, Chile and Brazil, community advocates and global health innovators. This is an invitation only event.
The global alliance for local and regional production and innovation: Equity in access
27 May, 12:30-14:30
The Government of Brazil, Ministry of Health, in collaboration with Unitaid, will host a high-level luncheon to address the critical need for equitable access to health technologies and innovation by expanding local and regional production, especially in low- and middle-income countries. This is an invitation only event.
Remarks from Dr. Philippe Duneton, Executive Director, Marisol Touraine, Executive Board Chair, and Tenu Avafia, Deputy Executive Director
Accelerating progress and action to close the women’s health gap: Promoting healthy and long lives for women
27 May, 16:00-17:30
Hosted by the Global Alliance for Women’s Health, this discussion will focus on the challenges and opportunities posed by women’s health issues, such as maternal mortality and cancer in women, that threaten the longevity and quality of life of women, with a focus on low- and middle-income countries.
Remarks from Marisol Touraine, Executive Board Chair
Second high-level meeting of the TB vaccine accelerator council
28 May, 7:30-9:00
A closed-door discussion on the critical need for robust and sustainable financing to accelerate the development, manufacture, and distribution of safe and effective TB vaccines worldwide.
Remarks from Dr. Philippe Duneton, Executive Director
Catalyzing innovation in health-related climate adaptation – scaling global action to support local needs
28 May, 8:00-9:30
A comprehensive look at global findings, practical strategies, case studies and promising innovations at the intersection of climate change and health.
Remarks from Vincent Bretin, Head of Results and Climate Team
Unitaid’s CEO roundtable
28 May, 12:00-14:00
Leaders of Unitaid’s closest partner organizations come together each year to discuss challenges, develop solutions and strengthen collaboration. This is closed event.
The dolutegravir story: A decade of access
28 May, 18:30-21:00
Ten years after the signing of the licensing agreements between the Medicines Patent Pool and ViiV, and with the support of Unitaid and numerous public health partners, more than 24 million adults and children living with HIV in 128 low- and middle-income countries are on affordable, best-in-class treatment. The dolutegravir story is a film premiere and panel discussion to showcase and learn from the successful collaboration in facilitating access to quality medicines.
Remarks from Dr. Philippe Duneton, Executive Director, and Robert Matiru, Director of Programs
Accelerating the end TB response: From high-level commitments to action
29 May, 8:00-10:00
This is a pivotal year for the fight to end TB, with a focus on turning high level commitments into tangible actions. The event will take stock of the progress made and outline key actions and innovations to rapidly ramp up the TB response to reach end TB targets.
Remarks from Dr Philippe Duneton, Executive Director
Devex roundtable discussion: Stepping up public-private cooperation and financing to prevent maternal and newborn deaths in humanitarian settings
29 May, 8:00-10:00
A multi-stakeholder roundtable discussion on how public-private cooperation and innovative financing can accelerate progress towards a world where every mother and newborn survive and thrive, even in the midst of a crisis.
Remarks from Janet Ginnard, Director of Strategy
Geneva Health Forum: What role can the vaccine play in eliminating malaria?
29 May, 11:30-13:00
This panel discussion will focus on the two malaria vaccines currently recommended by WHO, including the role vaccines can play in the malaria response, as well as the opportunities and challenges in implementing these tools as part of a holistic strategy.
Remarks from Dr. Philippe Duneton, Executive Director
Achieving better health for children – leadership and accountability for access to #BetterMeds4Kids
12:30-14:00
The Global Accelerator for Paediatric Formulations (GAP-f), with partners Drugs for Neglected Diseases, the Elizabeth Glaser Pediatric AIDS Foundation, Medicines for Malaria Venture, and the Medicines Patent Pool, are convening a dialogue among key stakeholders about how to strengthen and sustain political attention and accountability at the multilateral, regional and national levels on innovation and access to essential medicines for children.
Remarks from Janet Ginnard, Director of Strategy
SDG3 GAP progress report launch
29 May, 13:00-14:00
The Global Action Plan for Healthy Lives and Well-being for All (SDG3 GAP) aims to enhance collaboration among 13 global organizations engaged in health, development and humanitarian responses to accelerate country progress on the health-related SDG targets.
Remarks from Eva Nathanson, Head of Partnerships
Increasing access to medical oxygen: Local to global efforts
29 May, 17:00-19:30
One year after the launch of the Global Oxygen Alliance (GO2AL) and the adoption of the WHA resolution to increase access to medical oxygen by 194 Member States, this event will highlight national to global efforts – particularly partnerships – that are building stronger oxygen ecosystems. This is an invitation only event.
Remarks from Dr. Philippe Duneton, Executive Director, and Robert Matiru, Director of Programs
Accelerating vaccine and therapeutic production for health security in Africa
29 May, 18:00-20:30
A high-level event focused on ensuring the sustainability of regional manufacturing capacity for therapeutics and vaccines in Africa, including the mRNA Technology Transfer Program.
Remarks from Tenu Avafia, Deputy Executive Director